Table I Index
Table of Contents
|
Table I - 27 Grant Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
| Number | Rate | Number | Rate | Number | Rate | |
| All sites | 361 | 377.4 | 171 | 404.3 | 190 | 368.0 |
| Oral cavity and pharynx | 13 | 12.8** | 11 | 25.0** | * | # |
| Lip | * | # | * | # | * | # |
| Tongue | * | # | * | # | * | # |
| Major salivary glands | * | # | * | # | * | # |
| Floor of mouth | * | # | * | # | * | # |
| Gum and other mouth | * | # | * | # | * | # |
| Nasopharynx | * | # | * | # | * | # |
| Tonsil | * | # | * | # | * | # |
| Oropharynx | * | # | * | # | * | # |
| Hypopharynx | * | # | * | # | * | # |
| Pharynx and other oral cavity | * | # | * | # | * | # |
| Digestive system | 76 | 72.0 | 37 | 85.6 | 39 | 61.8 |
| Esophagus | * | # | * | # | * | # |
| Stomach | 5 | 4.7** | * | # | * | # |
| Small intestine | * | # | * | # | * | # |
| Colon excluding rectum | 44 | 40.6 | 17 | 39.2** | 27 | 40.9 |
| Rectum and rectosigmoid | 14 | 13.9** | 9 | 21.1** | 5 | 9.8** |
| Anus, anal canal, and anorectum | * | # | * | # | * | # |
| Liver and intrahepatic bile duct | * | # | * | # | * | # |
| Gallbladder | * | # | * | # | * | # |
| Other biliary | * | # | * | # | * | # |
| Pancreas | 6 | 6.2** | 6 | 13.7** | * | # |
| Retroperitoneum | * | # | * | # | * | # |
| Peritoneum | * | # | * | # | * | # |
| Other digestive organs | * | # | * | # | * | # |
| Respiratory system | 63 | 67.7 | 39 | 92.8 | 24 | 50.7 |
| Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
| Larynx | * | # | * | # | * | # |
| Lung and bronchus | 59 | 63.7 | 36 | 85.6 | 23 | 48.1 |
| Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
| Bones and joints | * | # | * | # | * | # |
| Soft tissue (including heart) | * | # | * | # | * | # |
| Skin (excluding basal and squamous) | 12 | 13.3** | 8 | 19.3** | * | # |
| Melanoma of the skin | 11 | 12.3** | 8 | 19.3** | * | # |
| Other non-epithelial skin cancers | * | # | * | # | * | # |
| Breast | 60 | 64.3 | * | # | 60 | 121.2 |
| Female genital system | 28 | 29.3 | -- | -- | 28 | 54.8 |
| Cervix uteri | 6 | 6.3** | -- | -- | 6 | 12.1** |
| Corpus uteri | 17 | 18.2** | -- | -- | 17 | 33.7** |
| Uterus, NOS | * | # | -- | -- | * | # |
| Ovary | * | # | -- | -- | * | # |
| Vagina | * | # | -- | -- | * | # |
| Vulva | * | # | -- | -- | * | # |
| Other female genital organs | * | # | -- | -- | * | # |
| Male genital system | 34 | 35.1 | 34 | 79.9 | -- | -- |
| Prostate gland | 30 | 30.3 | 30 | 70.1 | -- | -- |
| Testis | * | # | * | # | -- | -- |
| Penis | * | # | * | # | -- | -- |
| Other male genital organs | * | # | * | # | -- | -- |
| Urinary system | 28 | 28.2 | 15 | 34.7** | 13 | 25.2** |
| Urinary bladder | 16 | 15.5** | 13 | 29.7** | * | # |
| Kidney and renal pelvis | 11 | 11.9** | * | # | 9 | 17.9** |
| Ureter | * | # | * | # | * | # |
| Other urinary organs | * | # | * | # | * | # |
| Eye and orbit | * | # | * | # | * | # |
| Brain and other nervous system | 8 | 9.6** | 7 | 18.0** | * | # |
| Brain | 8 | 9.6** | 7 | 18.0** | * | # |
| Other nervous system | * | # | * | # | * | # |
| Endocrine system | 5 | 5.7** | * | # | * | # |
| Thyroid gland | * | # | * | # | * | # |
| Other endocrine (including thymus) | * | # | * | # | * | # |
| Lymphoma | 17 | 20.1** | 9 | 23.2** | 8 | 16.8** |
| Hodgkin’s disease | * | # | * | # | * | # |
| Non-Hodgkin’s lymphoma | 15 | 17.0** | 7 | 16.7** | 8 | 16.8** |
| Multiple myeloma | * | # | * | # | * | # |
| Leukemia | 7 | 8.2** | * | # | * | # |
| Acute lymphocytic | * | # | * | # | * | # |
| Chronic lymphocytic | * | # | * | # | * | # |
| Acute myeloid | * | # | * | # | * | # |
| Chronic myeloid | * | # | * | # | * | # |
| Other leukemias | * | # | * | # | * | # |
| Other, ill-defined and unknown sites | 5 | 5.7** | * | # | * | # |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |
||||||